BACKGROUND: There has been a gradual upward creep of revascularization thresholds for both fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR), before the clinical outcome trials for both indices. The increase in revascularization that has potentially resulted is at odds with increasing evidence questioning the benefits of revascularizing stable coronary disease. Using an independent invasive reference standard, this study primarily aimed to define optimal thresholds for FFR and iFR and also aimed to compare the performance of iFR, FFR, and resting distal coronary pressure (Pd)/central aortic pressure (Pa).
T he benefit of revascularization in stable coronary artery disease (CAD) is a contentious issue, with mounting evidence suggesting that patients on optimal medical therapy alone have an excellent prognosis with significantly improved symptoms, as suggested by the COURAGE trial 1 (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) and recently the sham-controlled ORBITA trial (Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina). 2 However, we have evidence suggesting physiology-guided revascularization, whether it be in the form of fractional flow reserve (FFR) [3] [4] [5] or instantaneous wave-free ratio (iFR), 6, 7 is associated with significantly improved symptoms and patient outcomes, compared with revascularization based on angiographic appearances alone. The benefits of revascularization seem to be greatest in those with a high burden of ischemia. 8, 9 The initial derivation studies of FFR were performed against a combination of noninvasive tests, including single photon emission computed tomography and stress echocardiography and showed an optimum threshold of 0.75. 3, 10 After this, subsequent evidence of improved clinical outcomes was demonstrated in the FAME 1 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) (showing a significant reduction in death and myocardial infarction within FFR-guided percutaneous coronary intervention [PCI] arm) 4 and the FAME 2 trial (driven by a reduction in repeat or urgent Revascularization), 4, 5 using the higher threshold of FFR ≤0.80, whereby clinicians were provided with the safety net of improved negative predictive value. FFR ≤0.80 has gained such wide acceptance as the dichotomous threshold to detect significant coronary disease that many novel physiological indices, including some noninvasive measures, 11 have been validated against it. The invasive physiological index of iFR was also originally derived and validated against an FFR ≤0.80 threshold. The ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) study and CLARIFY (Classification Accuracy of PressureOnly Ratios Against Indices Using Flow Study) suggested that iFR thresholds of 0.83 and 0.86 provided optimal agreement with the FFR threshold of 0.8, the latter using the ischemic arbiter of hyperemic stenosis resistance (hSR). Subsequent studies demonstrated discordance of up to 40% between FFR and iFR, 12 and, therefore, an iFR gray zone of 0.86 to 0.93 was suggested to allow clinicians to use iFR before clinical outcome data as this resulted in an improvement in concordance with FFR. 13 A drive for a discrete threshold led to further analyses of discordance 14, 15 and eventual adoption of a higher iFR threshold of ≤0.89 for the major clinical trials of iFRguided revascularization. Management of stable CAD using FFR ≤0.80 or iFR ≤0.89 has been shown to result in equivalent outcomes in recent trials in patients who generally have a good prognosis. 6, 7 Whether the loss of specificity inherent in this upward creep of the diagnostic FFR and iFR thresholds results in patients being inappropriately revascularized, in the absence of a substrate for ischemia, remains unclear.
This upward creep in thresholds has resulted in a physiological gray zone between the FFR 0.75 and 0.8 thresholds. Recent data from the IRIS-FFR registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve) by Kang et al 16 has suggested coronary revascularization of gray zone-FFR cases is not associated with improved outcomes. This gray zone has also existed for iFR (0.86-0.93), with a hybrid iFR-FFR guided strategy sometimes used to resolve the uncertainty. 13 However, recent randomized trials have used a single rule-in and rule-out iFR threshold of 0.89. 6, 7 This study aimed to assess the optimal diagnostic thresholds for these invasive physiological indices against an independent reference standard and in doing so, sought to also compare the diagnostic accuracy of these indices at both the contemporary and optimal thresholds. In the absence of a true ischemic gold standard, several noninvasive imaging methods have previously 
WHAT IS KNOWN

WHAT THE STUDY ADDS
• Contemporary thresholds of invasive physiological indices provide suboptimal diagnostic accuracy, compared with the original more stringent thresholds described in derivation studies. This may be leading to inappropriate treatment of vessels, which are not capable of causing ischemia.
• The findings of this study would also support using more robust and stringent thresholds in future trials comparing revascularization modalities and when assessing the efficacy of revascularization.
been used to further evaluate invasive physiological methods, with the major hurdle being these methods only isolate ischemia in a myocardial territory rather than a specific vessel. In this study, we, therefore, used hSR as an invasive reference standard of physiological significance. hSR is an invasive index calculated by measurement of both intracoronary pressure and Doppler flow velocity and so overcomes many of the limitations of flow-only and pressure-only based indices. [17] [18] [19] Some have suggested it as being more stenosis specific, having previously been used as an invasive reference standard to compare pressure-derived indices, for example, in the CLARIFY study. 20 It is considered to be independent of resting or hyperemic conditions within the vessel.
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METHODS
Study Population
Patients who were scheduled to undergo coronary angiography with a view to proceeding to PCI for suspected or confirmed stable ischemic heart disease were eligible for inclusion. Exclusion criteria were significant valvular heart disease, an unstable coronary presentation (myocardial in the prior 4 weeks or CCS IV angina), coronary disease that was not suitable for instrumentation (as below), previous coronary artery bypass surgery and contraindications to pharmacological hyperemia with adenosine. The study complies with the Declaration of Helsinki, and study protocols were approved by a national and locally appointed research ethics committee. All patients provided written informed consent. The data that support the findings of this study are available from the corresponding author on reasonable request.
Cardiac Catheterization
Dual antiplatelet therapy was initiated in all participants before the procedure. Diagnostic angiography was performed via the right radial artery or right femoral artery using 5F or 6F catheters. After diagnostic angiography, intracoronary pressure measurements were made with 6F guiding catheters. Bolus unfractionated heparin was administered to maintain an activated clotting time >250 seconds. After diagnostic coronary angiography intracoronary nitroglycerin was administered, and a 0.014" dual pressure-Doppler sensor guidewire (ComboWire, Volcano-Philips, CA) was calibrated to aortic pressure and the tip delivered to the distal epicardial vessel. Aortic pressure was measured via the fluid-filled guide catheter. The Doppler signal was optimized and recording commenced. Hyperemia was achieved using an intravenous infusion (dose 140 mcg/kg per minutes) or intracoronary boluses (dose 60 mcg repeated 3 times). 21 After completion of the infusion or each intracoronary bolus, we waited for baseline hemodynamic parameters (heart rate, blood pressure, and Doppler flow velocity) to return to baseline before the next measurement. At the end of physiological measurements, the pressure sensor was returned to the aorta, with measurements repeated if any pressure-drift was found. Offline calculation was subsequently performed of resting distal coronary pressure (Pd)/central aortic pressure (Pa), FFR, iFR, and hSR using Cardiac Waves Software (Kings College London, London, United Kingdom). Coronary angioplasty was then performed if indicated.
Data Recording and Analysis
Pressure Data
For Pd/Pa and iFR, analyses were performed in a fully automated manner without manual selection of data time points. iFR was calculated using the method described by Sen et al, 22 using a dedicated software package (CardiacWaves, King's College London, London, United Kingdom) that was designed with Matlab (Mathworks, Natick, MA) and has been previously validated against proprietary iFR measurements. 23, 24 In addition, we found our iFR data showed strong agreement with measurements made using proprietary software for a selection of cases from this study that had additional validation measurements with the volcano veratta wire data. FFR was calculated as the mean distal coronary pressure (measured with the pressure wire) divided by the mean aortic pressure (measured simultaneously with the guiding catheter) during maximal hyperemia. In cases where there was a phasic response to intravenous adenosine, the value recorded was the lower 5 beat average, as per the smart minimum method. 25 Where intracoronary adenosine was used, the lowest of 3 beat average reading was taken.
Pressure/Doppler Data
Peak coronary flow velocity, Pd, and Pa were ECG-gated and recorded continuously at a sampling frequency of 200 Hz and data exported into a custom-made StudyManager program (Academic Medical Center, University of Amsterdam, the Netherlands). The raw data were transferred to optical media, and hSR calculated using the dedicated MATLAB software (CardiacWaves, King's College London, London, United Kingdom). To account for beat-to-beat variability and reduce the effect of noise, signals were ensemble averaged over 5 consecutive cardiac cycles during stable hyperemia. Premature ectopic beats and the beat preceding were excluded from analysis. hSR was calculated as Pa−Pd/average peak flow velocity, with average peak flow velocity being average peak coronary flow velocity. The significant disease was defined by hSR ≥0.80.
Statistical Analysis
All data are expressed as medians (first quartile; third quartile) or means (SD) for continuous variables (compared using a t test or ANOVA for continuous normal distributed variables and Kruskal-Wallis test if continuous non-normal distributed); categorical variables are expressed as absolute and relative frequencies (compared using a Pearson χ 2 test). Hypothesis testing was 2-tailed and P<0.05 were considered statistically significant.
Diagnostic accuracy was quantified by the area under the receiver operating curve (AUC [95% CI] against hSR ≥0.8).
Bootstrapping was used to calculate CI, using 1000 stratified bootstrap replicates, to compare the AUC between indices and calculate the classification function. Diagnostic accuracy was calculated as Σ True positive+Σ True negative/Σ Total population for each threshold. Correlation was assessed with Pearsons R and adjusted R 2 by fitting a linear regression model. All statistical analyses were performed using R, version 3.4.3 GUI 1.70 (The R Foundation for Statistical Computing), using packages ggplot2, RMarkdown, pROC, and the tidyverse.
RESULTS
After exclusion of 6 cases because of poor Doppler flow signals, 75 consecutive patients between January 2015 to November 2017 were included in the study, with baseline demographics summarized in the Table. Mean age was 62 with 56 % male. One vessel was studied per patient, where FFR was 0.78±0.12 and iFR was 0.85±0. 
Diagnostic Performance of Invasive Resting and Hyperemic Indices
Receiver operator curves for the performance of iFR, FFR, and Pd/Pa in detecting an hSR value ≥0.8 are shown in Figure 2 . FFR had the best diagnostic accuracy (P=0.002 for comparison of AUC of FFR versus iFR and Pd/Pa). The AUC to predict hSR ≥0.8 was 0.92 (95% CI, 0.84-0.87), 0.79 (95% CI, 0.66-0.90), and 0.78 (95% CI 0.64 -0.9) for FFR, iFR, and resting Pd/Pa, respectively. Sensitivity, specificity, negative predictive value, and positive predictive value for the contemporary FFR threshold (≤0.80) were 89.3%, 73.5%, 92.5%, and 65.7%, respectively, with an overall diagnostic accuracy of 78.7%. Peak diagnostic accuracy was found at FFR thresholds of 0.75 to 0.76 (diagnostic accuracy 84%). Sensitivity, specificity, negative predictive value, and positive predictive value for the contemporary iFR threshold (≤0.89) were 78.3%, 58%, 82.9%, and 51.2%, respectively, with an overall diagnostic accuracy of 65.3%. Peak diagnostic accuracy was found at iFR thresholds of 0.85 to 0.86 (76%). Peak diagnostic accuracy for resting Pd/Pa was found at a threshold of 0.88 (55.6% Sensitivity, 89.8% specificity, 78.7% negative predictive value, 76% positive predictive value, and an overall diagnostic accuracy of 77.3%). A graphical representation of the diagnostic accuracy of different thresholds of FFR and iFR is shown in Figure 3 .
Using contemporary thresholds, there was discordance between FFR and iFR in 25.3% of cases with an equal number of cases where FFR +ve/iFR -ve and iFR +ve/FFR -ve. There was no significant difference (P>0.05) in baseline characteristics or coronary flow reserve (CFR) between these discordant groups. When adopting the optimal iFR and FFR thresholds from this study, the discordance between FFR and iFR fell to 10.7%.
DISCUSSION
The main findings of this study are follows: 1. The optimal diagnostic thresholds for FFR and iFR were found to be 0.75 and 0.86, respectively, which are in keeping with the thresholds identified when each index was originally derived. These thresholds provide superior diagnostic accuracy than contemporary thresholds for FFR (≤0.80) and iFR (≤0.89). 2. When comparing indices at optimal thresholds, FFR showed better diagnostic performance compared with the resting indices, iFR, and Pd/Pa, whereas the diagnostic accuracies of the latter are comparable. Our results suggest that contemporary iFR (0.89) and FFR (0.80) thresholds provide suboptimal diagnostic performance compared with the original thresholds from derivation studies. With evidence to suggest the benefits of revascularizing stable CAD may not be as significant as originally anticipated and many questioning the role of PCI in stable CAD, 2 the safety net of adopting higher thresholds with higher negative predictive values in exchange for lower overall diagnostic accuracy may be unjustified, particularly given the low event rate often seen in large trials of stable CAD. [4] [5] [6] [7] Adopting more rigorous thresholds means more targeted revascularization of those patients with a greater burden of ischemia: with significant evidence existing to suggest this may be of greater clinical benefit. The European Society of Cardiology Guidelines and recent American College of Cardiology/American Heart Association Appropriate Use Criteria recognize that patients with a greater burden of ischemia are higher risk and more likely to benefit from revascularization. 26, 27 The Hachamovitch et al 8 cohort study of over 10 000 patients showed revascularization compared with medical therapy had greater survival benefit (absolute and relative) in patients with moderate to large amounts of inducible ischemia, and this evidence was supported by the nuclear substudy of COURAGE, demonstrating that patients with a ≥5% reduction of ischemia on MPS had better outcomes from revascularization compared with medical therapy. 28 In addition, in recent years, metaanalysis of FFR data has suggested lesions with lower FFR values receive larger absolute benefits from revascularization, 9 with the analysis suggesting that an FFR as low as 0.67 provides optimal benefit for a composite involving death, myocardial infarction, and revascularization. Despite this weight of observational data, and data showing improved clinical outcomes out at 5 years using FFR-guided revascularization, 29 definitive evidence, in the form of adequately powered randomized trials, is still lacking to suggest better ischemic detection at lower thresholds translates to better clinical outcomes. Further evidence that revascularizing patients with greater ischemic burden yields greater patient benefit may come in the form of the ongoing ISCHEMIA trial (URL: https://www.clinicaltrials.gov. Unique identifier: NCT01471522). Until this trial reports, there exists substantial observational data to suggest patients with the greatest ischemic burden are likely to experience most benefit from revascularization and, therefore, the more rigorous iFR and FFR thresholds that this study supports may well translate into improved clinical outcomes.
Although our study is not the first to demonstrate significant discordance between FFR and iFR, it is the first to do so for modern thresholds using an invasive reference standard for ischemia resulting from epicardial CAD. Few studies have correlated iFR and FFR versus an independent reference standard. Petraco et al 30 used CFR as an independent reference to show that an iFR threshold of 0.9 had better diagnostic discrimination than an FFR of 0.8 (iFR AUC, 0.82; FFR AUC, 0.72; P<0.001). Using CFR as a gold standard for invasive physiological measures of epicardial coronary disease may be significantly confounded by its dependence on external hemodynamics, including aortic pressure, heart rate, and resting microvascular resistance. FFR is generally accepted to be less dependent on external factors, with De Bruyne et al 31 demonstrating no significant change in values when aortic pressure, myocardial contractility, and heart rate were manipulated in vivo across normal physiological ranges. However, subsequent modeling and bench work by Siebes et al 19 suggested that pressure-derived indices may be somewhat more dependent on aortic pressure, particularly in circumstances where Pa is low in patients with high coronary outflow pressure. It is, therefore, important to realize that all currently available indices of stenosis severity, not just CFR, may be dependent on microvascular resistance and external hemodynamic factors to varying degrees, particularly around the clinically relevant gray zone.
Other studies to compare iFR and FFR (at contemporary thresholds) versus invasive reference standard for ischemia include the study by Hwang et al, 32 who used positron emission tomography relative flow reserve to show no significant difference in AUC between iFR and FFR (iFR AUC, 0.77; FFR AUC, 0.83; P=0.05) but with FFR showing better discriminatory ability when compared with an iFR threshold of 0.9, in keeping with the findings of our study.
Sen et al 20 previously also used hSR, to show the similar diagnostic performance of iFR and FFR in 51 patients (iFR AUC, 0.93; FFR AUC, 0.96; P=0.48), although this study included patients with a milder spectrum of disease; less than two-thirds were within the diagnostically challenging range 0.60 to 0.90. In comparison to these studies, we present the largest cohort (n=75) in which an invasive reference standard for ischemia has been applied 17, 18 with 80% of patients in our study within the diagnostically uncertain FFR range between 0.6 and 0.9.
The implications of this work are wide-ranging, including support for those who recommend reverting away from binary thresholds and instead using a grayzone approach: using clinical judgment for revascularization when the value falls in the gray zone. 33 For example, there is some evidence to suggest PCI of lesions with FFR between 0.75 and 0.80 is associated with greater clinical benefit for proximal lesions. 34 A gray-zone approach to resting indices may be of even further value given the narrower bandwidth at which these indices are commonly used. The results of our study also support moving away from a gray-zone approach in favor of considering using the original and more stringent thresholds in future studies of both FFR and iFR: further supported by the recent data by Kang et al 16 suggesting PCI of gray zone-FFR cases do not derive net clinical benefit.
If future trials for physiology-guided revascularization did use more stringent thresholds, this would mean revascularization is reserved for a higher risk cohort, which may yield greater benefit than the surprisingly modest outcomes and weak symptom benefit suggested by some recent trials of PCI for stable CAD.
1,2
Study Limitations
We recognize there is currently no gold standard ischemia test, and this is reflected by the fact previous studies have used PET, CFR, and hSR as a reference standard, without consensus. We used hSR, as this is the most theoretically robust invasive vessel-specific physiological test, which is known to have greater accuracy in detecting inducible ischemia 17 and has previously been used in derivation work of pressure-derived indices of stenosis severity. 20 However, hSR lacks the prognostic evidence base that the pressure-derived indices have and given the steep learning curve, its use is limited to the research arena.
We acknowledge that stenosis resistance can also be measured in resting conditions, but small errors in pressure and flow velocity may result in relatively large errors, making this inappropriate for reference standard. Therefore, a potential explanation for our additional finding of FFR superiority over iFR is the use of a hyperemic index as the reference standard test. That said, hyperemic conditions continue to be widely recognized as the reference standard against which novel invasive indices are often adjudged, including in the recent derivation work of resting indices. 20 We also recognize that this study has a relatively small sample size from a single-center. While it is certainly the largest study of its kind, lend support to a large multicenter randomized study, rather than being practice changing per se.
Conclusions
Modern FFR and iFR thresholds provide suboptimal diagnostic accuracy compared with an FFR threshold of 0.75 or an iFR threshold of 0.86 respectively, which are also the binary cutoffs from the original derivation studies. FFR had better diagnostic accuracy than either of the resting indices, iFR, and Pd/Pa. When used to guide treatment, the less specific contemporary thresholds could lead to inappropriate treatment of vessels. Whether the use of the more rigorous thresholds would result in the selection of a population gaining greater symptom and prognostic benefit needs to be assessed in future studies of physiology-guided revascularization.
